Severe symptomatic aortic stenosis
Breathlessness, chest pain, fainting, heart failure, or reduced activity with severe aortic valve narrowing should prompt valve-team review.
Cardiac procedure guide
TAVR, also called TAVI in many countries, replaces a narrowed aortic valve through a catheter instead of conventional open chest surgery. It is most often discussed for older patients or patients with higher surgical risk, but suitability depends on echo severity, CT valve sizing, vascular access, calcium pattern, kidney function, rhythm risk, life expectancy, and the availability of an experienced structural heart team.
Who is usually evaluated for TAVR?
TAVR is usually evaluated in patients with severe symptomatic aortic stenosis, especially when open surgery carries higher risk because of age, frailty, prior surgery, lung disease, kidney disease, or other illnesses. Younger or lower-risk patients may still be better served by open valve surgery depending on anatomy, durability needs, valve size, coronary access, and lifetime treatment strategy.
Candidate fit
Breathlessness, chest pain, fainting, heart failure, or reduced activity with severe aortic valve narrowing should prompt valve-team review.
Age, frailty, lung disease, kidney disease, prior chest surgery, weak heart function, or other conditions can make catheter treatment attractive.
Selected patients may recover more quickly than with open surgery, although safety depends on anatomy and hospital experience.
Some patients with failing surgical tissue valves may be evaluated for valve-in-valve TAVR if anatomy permits.
What it treats
The most common TAVR scenario is a stiff, calcified aortic valve that restricts blood flow from the heart.
Frailty assessment helps decide whether TAVR benefit is likely and what recovery support will be needed.
Low ejection fraction or low-flow states need expert echo and CT interpretation before choosing TAVR or surgery.
Valve-in-valve TAVR may be possible in selected patients with a deteriorating previous tissue valve.
Procedure approach
Technique choice can affect cost, hospital stay, recovery speed, risk profile, and follow-up requirements.
TAVR is device-led and imaging-led; the planning quality matters as much as the procedure day.
The team confirms severe aortic stenosis, valve gradients, valve area, heart function, leakage, and other valve disease before procedure planning.
CT checks annulus size, calcium, coronary height, aorta, leg arteries, and access safety so the valve size and route are chosen correctly.
Structural cardiology, cardiac surgery, anesthesia, imaging, and ICU teams should agree that TAVR is the right route for the patient.
The approach changes by anatomy and risk rather than by patient preference alone.
The valve is delivered through the femoral artery in the leg and deployed inside the old aortic valve without stopping the heart.
If leg arteries are unsuitable, selected centers may consider another access route, which can alter risk, recovery, and cost.
A catheter valve can sometimes be placed inside an older failing tissue valve, but CT review is essential for coronary obstruction risk.
Reports before planning
Reports help doctors confirm whether the procedure is suitable and what can change the treatment plan after arrival.
Preparation
Ask why TAVR is preferred over open replacement for this patient and what anatomy supports that decision.
Do not rely only on echo. TAVR requires CT measurements to reduce sizing, access, and coronary-risk surprises.
Baseline conduction disease can raise the chance of needing a pacemaker after TAVR, so the estimate and consent should mention it.
Older patients may need attendant support, fall prevention, medication reminders, and extra nights near the hospital after discharge.
Hospital stay
The hospital verifies imaging, kidney protection, valve availability, anesthesia plan, blood tests, consent, and emergency backup.
The catheter valve is positioned and expanded inside the diseased aortic valve under imaging guidance in a cath lab or hybrid setup.
After TAVR, the team watches conduction changes, bleeding, leg artery issues, kidney function, stroke signs, and valve performance.
Before discharge, patients usually receive echo review, ECG review, medicine instructions, wound checks, and follow-up timing.
Recovery
Monitoring focuses on rhythm stability, blood pressure, access site, kidney function, walking, and neurological checks.
Many patients improve breathing and walking gradually, but fatigue, bruising, medicine changes, and rhythm monitoring are still important.
Follow-up echo, ECG, symptom review, and wound checks help confirm valve performance and detect late conduction issues.
Patients need periodic echo, infection prevention guidance, cardiology follow-up, and medicine adherence after returning home.
Risks and safety questions
TAVR can disturb heart conduction, and some patients require permanent pacemaker implantation.
Ask if pacemaker cost is included or separate.
Large artery access can cause bleeding, vessel injury, or bruising, especially in calcified vessels.
CT access mapping reduces surprises.
Valve calcium and catheter movement can carry a stroke risk.
Discuss prevention steps and monitoring.
Leakage around the new valve can occur and may need additional treatment or follow-up.
Post-procedure echo checks this.
Contrast dye and procedure stress can affect kidney function.
Kidney-risk planning matters before CT and TAVR.
India advantages
Major Indian metros have structural heart programs that evaluate TAVR with imaging, cardiac surgery backup, and ICU support.
A proper estimate can name the valve device, valve size assumptions, imaging, cath lab, ICU, and pacemaker contingency.
TAVR can suit patients who need a shorter recovery path, provided the anatomy and valve-team review support it.
High-value TAVR usually fits advanced metros such as Delhi NCR, Chennai, Mumbai, Bangalore, Hyderabad, or Gurgaon rather than every city.
Cost range and variables
TAVR in India often ranges around $18,000-$38,000+, mainly because the valve device itself is costly.
Valve brand and size must be visible.
TAVR protocol CT, echo, angiography, and blood tests add to planning cost but are essential for safety.
Avoid skipping sizing work.
Some patients need permanent pacemaker implantation after TAVR, which can add a significant separate cost.
Ask about this before admission.
Delhi NCR, Mumbai, Chennai, Bangalore, Hyderabad, and Gurgaon usually offer deeper structural heart ecosystems for TAVR.
Tier 2 use is more selective.
Vascular repair, kidney support, stroke care, or longer monitoring can raise the final bill.
High-risk patients need buffer planning.
Hospital selection
Choose a center with regular TAVR work, advanced imaging, cath lab or hybrid OT, cardiac surgery backup, and experienced ICU care.
This is not a routine cath lab procedure.
Hospitals should provide systematic CT measurement and explain valve sizing, access route, and coronary-risk assessment.
Sizing drives safety.
Electrophysiology and pacemaker implantation should be available if conduction problems occur after TAVR.
This backup is important.
The estimate should name the valve device, imaging, cath lab, ICU, room stay, and exclusions clearly.
Device ambiguity is expensive.
Doctor selection
Ask about TAVR volume, valve systems used, alternative access experience, and management of high-risk anatomy.
Experience matters for device-led care.
Even when TAVR is planned, cardiac surgery input helps compare open replacement and backup options.
A heart-team approach is stronger.
TAVR depends on accurate echo and CT interpretation, so imaging review should be part of the plan.
Measurements must be reliable.
The doctor should explain recovery, fall risk, medicines, pacemaker risk, and follow-up in language the family can act on.
Practical guidance matters after discharge.
Questions
No. TAVR is a catheter-based aortic valve replacement and usually does not require opening the chest or stopping the heart. It still needs advanced imaging, specialist planning, and hospital monitoring.
Patients may not be suitable if anatomy is unfavorable, valve disease is not severe, another valve problem dominates, infection is active, access vessels are unsafe, or long-term durability strategy favors surgery.
A broad planning range is about $18,000-$38,000+, with the valve device, CT planning, hospital city, ICU stay, and pacemaker need driving the final estimate.
TAVR should be limited to centers with structural heart experience, CT planning, cath lab or hybrid setup, cardiac surgery backup, ICU support, and pacemaker availability. This usually points to major metros.
The aortic valve sits close to the heart conduction system. Valve deployment can disturb electrical signals in some patients, especially those with existing conduction disease.
Many patients need a shorter stay than open surgery, but international planning should allow time for CT, procedure, rhythm monitoring, follow-up echo, wound review, and travel clearance.
It depends on risk, age, anatomy, valve durability needs, coronary access, and lifetime strategy. A heart-team review should compare both paths rather than assuming one is better.
Yes. Virello can help organize echo and CT review, compare valve-team recommendations, check device assumptions, and match the patient to suitable Indian cardiac centers.
Continue planning
Review device-led pricing and pacemaker cost variables.
Compare open valve replacement when TAVR is not the best fit.
Understand rhythm-device planning after valve procedures.
Prepare heart reports and treatment questions.
Compare a major metro route for advanced cardiac care.
Request a report-based TAVR estimate with device assumptions.